Monthly Archives: April 2019

Treatment of malignant mesothelioma (PDQ®) -Version for patients

General information about Treatment of malignant mesothelioma (PDQ®) -Version for patients IMPORTANT POINTS Malignant mesothelioma is a disease in which malignant (cancerous) cells form in the lining of the chest or abdomen. Exposure to asbestos (asbestos) influences the risk of malignant mesothelioma. The signs and symptoms of malignant mesothelioma include shortness of breath and pain below the ribs. To detect ...

Read More »

CAR T-Cell Therapy for Mesothelioma Proving Effective in Clinical Trial

Dr. Prasad Adusumilli at Memorial Sloan Kettering Cancer Center believes novel CAR T-cell therapy will be part of future, standard-of-care treatment for malignant pleural mesothelioma. The therapy involves the laboratory reprograming of a patient’s T cells — a type of white blood cell — to attack the cancer by targeting mesothelin, a surface protein. CAR T-cell therapy is a form of immunotherapy ...

Read More »